{"id":"W3010131774","doi":"10.1200/jco.2007.25.18_suppl.540","title":"Competing causes of death in NCIC CTG MA.17, a placebo-controlled trial of letrozole as extended adjuvant therapy for breast cancer patients","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Breast cancer; Letrozole; Internal medicine; Tamoxifen; Oncology; Clinical endpoint; Placebo; Cancer; Gynecology; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004694337,0.0002021083,0.003102062,0.0002741606,0.00002557048,0.000002532087,0.0001942679,0.0003109664,0.0001472956],"category_scores_gemma":[0.002412818,0.0001394892,0.0007243514,0.0001664361,0.0002233832,0.0001034589,0.00002924174,0.0006291769,7.172468e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003002211,"about_ca_system_score_gemma":0.001771173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008697501,"about_ca_topic_score_gemma":0.0001838678,"domain_scores_codex":[0.9944825,0.0003413902,0.004096456,0.0002091585,0.0005034962,0.0003669786],"domain_scores_gemma":[0.9893103,0.00496989,0.004256479,0.0001764637,0.001059076,0.000227769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7497892,0.004173743,0.0624535,0.00003645965,0.0005426273,0.0000463035,0.0002110344,0.00005059779,0.0008646652,0.00003645694,0.00002819033,0.1817672],"study_design_scores_gemma":[0.6307483,0.02359963,0.3414051,0.0003287127,0.000232692,0.00007541415,0.0002565898,0.00003520887,0.0006091306,0.0003247619,0.002279659,0.0001048648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941689,0.001010375,0.0003311923,0.001214999,0.001260563,0.001605363,0.00002832434,0.000006224758,0.0003740511],"genre_scores_gemma":[0.9945441,0.0005494814,0.002670979,0.0009249626,0.001167159,0.00003854572,0.000002016973,0.00002986367,0.000072912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2789516,"threshold_uncertainty_score":0.5688207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07493129269012377,"score_gpt":0.4723784039412525,"score_spread":0.3974471112511287,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}